CORT vs HOOD · P/E 199, rev $421.1M vs P/E 48, rev $2.38B
Corcept Therapeutics Incorporated (CORT) versus Robinhood Markets Inc (HOOD) — a side-by-side from cached financials, not a winner call.
Corcept Therapeutics Incorporated (CORT) is a biotechnology company listed on US.
Robinhood Markets Inc (HOOD) is a capital markets company listed on NASDAQ. It is led by Vlad Tenev.
Latest reported CORT revenue for 2026-06-30 was $421.1M. Net income was $11.2M. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
Latest reported HOOD revenue for 2026-06-30 was $2.38B. Net income was $911.0M. HOOD currently screens at market cap $88.36B and trailing P/E 47.6.
CORT currently screens at market cap $7.46B and trailing P/E 198.5. HOOD currently screens at market cap $88.36B and trailing P/E 47.6.
Not investment advice. Open the CORT and HOOD stock pages for the full models.
Not investment advice.